Autologous umbilical cord blood transfusion in very young children with type 1 diabetes

Diabetes Care

Volumn 32, Issue 11, 2009, Pages 2041-2046

  Haller, Michael J ^a   Wasserfall, Clive H ^b   McGrail, Kieran M ^b   Cintron, Miriam ^a   Brusko, Todd M ^c   Wingard, John R ^a   Kelly, Susan S ^d   Shuster, Jonathan J ^b   Atkinson, Mark A ^b   Schatz, Desmond A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; C PEPTIDE; HEMOGLOBIN A1C; INSULIN;

ANTIBODY TITER; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD CELL; CD4 CD8 RATIO; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE COUNT; MALE; METABOLIC RATE; PHENOTYPE; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; TREATMENT OUTCOME; UMBILICAL CORD BLOOD;

BLOOD GLUCOSE; BLOOD TRANSFUSION, AUTOLOGOUS; C-PEPTIDE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FETAL BLOOD; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFUSIONS, INTRAVENOUS; INSULIN; LEUKOCYTE COUNT; TIME FACTORS;

EID: 70449415668     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc09-0967     Document Type: Article

References (25)

1. Silverstein J, Maclaren N, Riley W, Spillar R, Radjenovic D, Johnson S. Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N Engl J Med 1988;319:599-604 (Pubitemid 18209708)
2. Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Chéramy M, Pihl M, Vaarala O, Forsander G, Ivarsson S, Johansson C, Lindh A, Nilsson NO, Aman J, Ortqvist E, Zerhouni P, Casas R. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med 2008;359:1909-1920
3. Skyler JS, Krischer JP, Wolfsdorf J, Cowie C, Palmer JP, Greenbaum C, Cuthbertson D, Rafkin-Mervis LE, Chase HP, Leschek E. Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial-Type 1. Diabetes Care 2005;28:1068-1076 (Pubitemid 40616615)
4. Herold KC, Gitelman SE, Masharani U, Hagopian W, Bisikirska B, Donaldson D, Rother K, Diamond B, Harlan DM, Bluestone JA. A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes. Diabetes 2005;54:1763-1769
5. Denner L, Bodenburg Y, Zhao JG, Howe M, Cappo J, Tilton RG, Copland JA, Forraz N, McGuckin C, Urban R. Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Proliferation 2007;40:367-380 (Pubitemid 46802188)
6. Beilhack GF, Scheffold YC, Weissman IL, Taylor C, Jerabek L, Burge MJ, Masek MA, Shizuru JA. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 2003;52:59-68 (Pubitemid 36042108)
7. Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA, Bhatia M. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003;21:763-770 (Pubitemid 36791394)
8. Limbert C, Päth G, Jakob F, Seufert J. Beta-cell replacement and regeneration: Strategies of cell-based therapy for type 1 diabetes mellitus. Diabetes Res Clin Pract 2008;79:389-399
9. Hussain MA, Theise ND. Stem-cell therapy for diabetes mellitus. Lancet 364:203-205
10. Couri CE, Foss MC, Voltarelli JC. Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration. Braz J Med Biol Res 2006;39:1271-1280
11. Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun 2004;325:665-669 (Pubitemid 39489894)
12. Haller M, Viener H, Brusko T, Wasserfall C, McGrail K, Staba S, Cogle C, Atkinson M, Schatz D. Insulin requirements, HbA1c, and stimulated C-peptide following autologous umbillical cord blood transfusion in children with type 1 diabetes (Abstract). Diabetes 2007;56(Suppl.1):A82
13. Viener H, Brusko T, Wasserfall C, McGrail K, Staba S, Cogle CA, MA, Schatz D, Haller M. Changes in regulatory T cells following autologous umbillical cord blood transfusion in children with type 1 diabetes (Abstract). Diabetes 2007;56(Suppl. 1):A82
14. Voltarelli JC, Couri CE, Stracieri AB, Oliveira MC, Moraes DA, Pieroni F, Coutinho M, Malmegrim KC, Foss-Freitas MC, Simões BP, Foss MC, Squiers E, Burt RK. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007;297:1568-1576 (Pubitemid 46588370)
15. Godfrey WR, Spoden DJ, Ge YG, Baker SR, Liu B, Levine BL, June CH, Blazar BR, Porter SB. Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005;105:750-758 (Pubitemid 40070762)
16. Fruchtman S. Stem cell transplantation. Mt Sinai J Med 2003;70:166-170
17. Han P, Hodge G, Story C, Xu X. Phenotypic analysis of functional T-lymphocyte subtypes and natural killer cells in human cord blood: relevance to umbilical cord blood transplantation. Br J Haematol 1995;89:733-740
18. Haller MJ, Viener HL, Wasserfall C, Brusko T, Atkinson MA, Schatz DA. Autologous umbilical cord blood infusion for type 1 diabetes. Exp Hematol 2008;36:710-715
19. Group D-S. The Diabetes Prevention Trial Type 1 Diabetes (DPT-1). Diabetes 1994;43(Suppl. 1):159A
20. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study.NEngl J Med 1998;338:1650-1656
21. Brusko T, Atkinson M. Treg in type 1 diabetes. Cell Biochem Biophys 2007;48:165-175
22. Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D, Haller M, Rockell J, Gottlieb P, Clare-Salzler M, Atkinson M. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes 2007;56:604-612
23. Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 2005;54:1407-1414
24. Smith L, Haller MJ, Staba-Kelly S. Characteristics and cell composition of privately banked autologus cord blood (UCB) units utilized for autologous infusion in children with type I diabetes. Biol Blood Marrow Transplant 2008;14:75
25. Schatz D, Gale EA, Atkinson MA. Why can't we prevent type 1 diabetes?: maybe it's time to try a different combination. Diabetes Care 2003;26:3326-3328